Psilocybin and MDMA may be used to rewire the brain, potentially increasing oxytocin and serotonin levels.

“And I just want to mention that there are clinical trials, meaning legal clinical trials being done at Johns Hopkins School of Medicine by Matthew Johnson and others, exploring how drugs like MDMA, which increases dopamine and serotonin to very high levels or siliciden so-called magic mushrooms, which increases serotonin and other compounds to very high levels within the confines of a professionally supported therapeutic environment can help people rewire their brain, such that they can get relief from major depression and various forms of trauma. And now eating disorders are also being explored in the context of MDMA and siliciden clinical trials.”